Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biotechnology and Bioengineering

• Publication date

  2003-07-05

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1002/BIT.10644PMID 12740932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells

  2004cited by this paper
• E1B-Deleted Adenovirus (dl1520) Gene Therapy for Patients with Primary and Secondary Liver Tumors

  2001cited by this paper
• Chapter 11. Aeration in Cell Culture Bioreactors

  2001cited by this paper
• Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies.

  2000cited by this paper
• Adenovirus p16 gene therapy for prostate cancer

  2000cited by this paper
• Sparging and agitation‐induced injury of cultured animals cells: Do cell‐to‐bubble interactions in the bulk liquid injure cells?

  2000cited by this paper
• Animal-cell damage in sparged bioreactors.

  2000cited by this paper
• Cell death from bursting bubbles: Role of cell attachment to rising bubbles in sparged reactors

  1999cited by this paper
• Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset

  1999cited by this paper
• Problems in predicting cell damage from bubble bursting.

  1999cited by this paper
• Comparison of manufacturing techniques for adenovirus production

  1999cited by this paper
• Cell death from bursting bubbles: role of cell attachment to rising bubbles in sparged reactors.

  1999cited by this paper
• A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy

  1998cited by this paper
• Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.

  1998cited by this paper
• New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses

  1998cited by this paper
• Analytical Anion-Exchange HPLC of Recombinant Type-5 Adenoviral Particles

  1997cited by this paper
• Effects of surface-active medium additives on insect cell surface hydrophobicity relating to cell protection against bubble damage

  1997cited by this paper
• Analysis of cell‐to‐bubble attachment in sparged bioreactors in the presence of cell‐protecting additives

  1995cited by this paper
• Mechanisms of animal cell damage associated with gas bubbles and cell protection by medium additives.

  1995cited by this paper
• Transduction of Human Bone Marrow by Adenoviral Vector

  1994cited by this paper
• Quantification of damage to suspended insect cells as a result of bubble rupture

  1994cited by this paper
• Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model.

  1994cited by this paper
• Quantitative and mechanistic effects of bubble aeration on animal cells in culture

  1993cited by this paper
• Cell Death in the Thin Films of Bursting Bubbles

  1992cited by this paper
• Effect of serum concentration on hybridoma viable cell density and production of monoclonal antibodies in cstrs and on shear sensitivity in air‐lift loop reactors

  1992cited by this paper
• Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys.

  1991cited by this paper
• Lethal events during gas sparging in animal cell culture

  1991cited by this paper
• Media additives for protecting freely suspended animal cells against agitation and aeration damage.

  1991cited by this paper
• Damage mechanisms of suspended animal cells in agitated bioreactors with and without bubble entrainment

  1990cited by this paper
• Effect of gas—liquid interfaces on the growth of suspended mammalian cells: mechanisms of cell damage by bubbles

  1989cited by this paper
• Bubble-column design for growth of fragile insect cells

  1988cited by this paper
• Scaleup of Insect Cell Cultures: Protective Effects of Pluronic F-68

  1988cited by this paper
• On the evaluation of gas-liquid interfacial effects on hybridoma viability in bubble column bioreactors.

  1987cited by this paper

• Virus‐like particles as powerful vaccination strategy against human viruses

  2023cites this paper
• Platforms, advances, and technical challenges in virus-like particles-based vaccines

  2023cites this paper
• Consumer Acceptance and Production of In Vitro Meat: A Review

  2022cites this paper
• Optimization of an adenovirus-vectored zoster vaccine production process with chemically defined medium and a perfusion system

  2022cites this paper
• Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis

  2021cites this paper
• Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine

  2021cites this paper
• Viruses and Virus-Like Particles in Biotechnology: Fundamentals and Applications

  2019cites this paper
• Bioreactors in Regenerative Medicine

  2019cites this paper
• Advancements in the design and scalable production of viral gene transfer vectors

  2018cites this paper
• MODELING AND SIMULATION OF 1Gessiel

  2017cites this paper
• Impact of Pluronic® F68 on hollow fiber filter-based perfusion culture performance

  2017cites this paper
• Present Situation of Viral Vector Manufacturing and Ways to Overcome Potential Barriers in View of the Routine Large Scale Production and Use of Viral Vectors

  2017cites this paper
• Viral vectors for gene therapy and gene modification approaches

  2016cites this paper
• Emerging platform bioprocesses for viral vectors and gene therapies

  2016cites this paper
• Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.

  2015cites this paper
• Cell substrates for the production of viral vaccines.

  2015cites this paper
• Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions.

  2015cites this paper
• Manufacturing of viral vectors for gene therapy: part I. Upstream processing

  2014cites this paper
• High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.

  2014cites this paper
• Virus Production Under Suspension Conditions

  2014cites this paper
• Bioreactor engineering using disposable technology for enhanced production of hCTLA4Ig in transgenic rice cell cultures

  2013influential citation
• Process Characterization of hCTLA4Ig Production in Transgenic Rice Cell Cultures Using a 3-L Bioreactor

  2013cites this paper
• Vaccine process technology

  2012cites this paper
• Viral Vectors for Gene Therapy

  2011cites this paper
• Viruses and Virus-Like Particles in Biotechnology

  2011cites this paper
• Production of adenovirus vectors and their use as a delivery system for influenza vaccines

  2010cites this paper
• Adenovirus vector production and purification.

  2010cites this paper
• Production and Purification of Adenovirus Vectors for Gene Therapy

  2010cites this paper
• Virus-like particles in vaccine development

  2010cites this paper
• Gene Expression: Human Cells

  2009cites this paper
• From the first to the third generation adenoviral vector: what parameters are governing the production yield?

  2009cites this paper
• Industrial bioprocesses: beyond routine applications of established methodologies.

  2009cites this paper
• 293 cell cycle synchronisation adenovirus vector production

  2009cites this paper
• Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions.

  2008cites this paper
• Pilot‐Scale Adenovirus Seed Production through Concurrent Virus Release and Concentration by Hollow Fiber Filtration

  2008cites this paper
• Microwell evaluation of mammalian cell lines for large scale culture

  2008cites this paper
• Scaleable Production of Adenoviral Vectors by Transfection of Adherent PER.C6 Cells

  2007cites this paper
• Cell Culture Processes for the Production of Viral Vectors for Gene Therapy Purposes

  2006cites this paper
• Fluid mixing in shaken bioreactors: Implications for scale-up predictions from microlitre-scale microbial and mammalian cell cultures

  2006cites this paper
• A Systematic Approach for Scale‐Down Model Development and Characterization of Commercial Cell Culture Processes

  2006cites this paper
• Reactores para culturas de células vegetais

  2006cites this paper
• Metabolism of PER.C6TM cells cultivated under fed‐batch conditions at low glucose and glutamine levels

  2006influential citation
• Quantitation of adenovirus type 5 empty capsids.

  2006cites this paper
• Non-replicating viral vector-based AIDS vaccines: interplay between viral vectors and the immune system.

  2005cites this paper
• Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

  2005cites this paper
• Mechanical stress on suspended particles in two- and three-phase airlift loop reactors and bubble columns

  2005cites this paper
• Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA.

  2005cites this paper
• Production and formulation of adenovirus vectors.

  2005cites this paper
• Versatility of gene therapy vectors through viruses

  2005cites this paper
• Good Manufacturing Practice Production of Adenoviral Vectors for Clinical Trials

  2005cites this paper
• Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector.

  2005cites this paper
• Serotype Specificity of Adenovirus Purification Using Anion-Exchange Chromatography

  2005cites this paper
• Cultures de cellules immortalisees par e1 et procedes de culture de ces dernieres visant a en augmenter les rendements de produits

  2004cites this paper
• Experimental Study of a Ceramic Microsparging Aeration System in a Pilot‐Scale Animal Cell Culture

  2004cites this paper
• Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors

  2004cites this paper